{
    "Atezolizumab + Carboplatin + Etoposide (ES-SCLC)": {
        "name": "Atezolizumab + Carboplatin + Etoposide Regimen",
        "description": "Atezolizumab with Carboplatin and Etoposide for first-line treatment of extensive-stage small cell lung cancer (ES-SCLC); 4 cycles with atezolizumab maintenance",
        "schedule": [
            {
                "day": 1,
                "description": "Atezolizumab",
                "cycles": [
                    1,
                    2,
                    3,
                    4
                ]
            },
            {
                "day": 1,
                "description": "Carboplatin (AUC 5\u20136)",
                "cycles": [
                    1,
                    2,
                    3,
                    4
                ]
            },
            {
                "day": 1,
                "description": "Etoposide",
                "cycles": [
                    1,
                    2,
                    3,
                    4
                ]
            },
            {
                "day": 2,
                "description": "Etoposide",
                "cycles": [
                    1,
                    2,
                    3,
                    4
                ]
            },
            {
                "day": 3,
                "description": "Etoposide",
                "cycles": [
                    1,
                    2,
                    3,
                    4
                ]
            },
            {
                "day": 1,
                "description": "Atezolizumab (maintenance)",
                "cycles": [
                    5,
                    6,
                    7,
                    8,
                    9,
                    10,
                    11,
                    12
                ]
            }
        ],
        "cycle_days": 21,
        "total_cycles": 12
    }
}
